Inventor
HOENER MARIUS
CH25 patents
⚠️ This page may combine multiple inventors who share the name “HOENER MARIUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
17 patentsUS11852627B2Dec 26, 2023
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US11320421B2May 3, 2022
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US12259380B2Mar 25, 2025
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE2 citations73
US10457644B2Oct 29, 2019
Pyrazol compounds as EAAT3 inhibitors
HOFFMANN LA ROCHE2 citations73
US10457663B2Oct 29, 2019
Pyrazol-pyridine derivatives
HOFFMANN LA ROCHE2 citations73
US10273217B2Apr 30, 2019
Triazole derivatives
HOFFMANN LA ROCHE2 citations73
US10092546B2Oct 9, 2018
Imidazole derivatives
HOFFMANN LA ROCHE3 citations73
US10029989B2Jul 24, 2018
Imidazole derivatives
HOFFMANN LA ROCHE2 citations73
US10005736B1Jun 26, 2018
Pyridine and pyrimidine derivatives
HOFFMANN LA ROCHE6 citations73
US11312711B2Apr 26, 2022
Morpholine derivative
HOFFMANN LA ROCHE0 citations62
US7875645B2Jan 25, 2011
Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives
HOFFMANN LA ROCHE2 citations62
US12566172B2Mar 3, 2026
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE0 citations61
US10577332B2Mar 3, 2020
Tetrazole derivatives
HOFFMANN LA ROCHE0 citations52
US10508107B2Dec 17, 2019
Morpholine derivative
HOFFMANN LA ROCHE0 citations52
US10155741B2Dec 18, 2018
Pyridine or pyrimidine derivatives
HOFFMANN LA ROCHE0 citations52
US10556870B2Feb 11, 2020
Imidazole compounds as EAAT3 inhibitors
HOFFMANN LA ROCHE0 citations42
US7268154B2Sep 11, 2007
Substituted triazole compounds
HOFFMANN LA ROCHE0 citations39
ROCHE INNOVATION CT COPENHAGEN AS
3 patentsUS10494633B2Dec 3, 2019
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS8 citations91
US10739332B2Aug 11, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS6 citations82
US10718753B2Jul 21, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS5 citations82
HOENER MARIUS
2 patentsUS9132136B2Sep 15, 2015
Pharmaceutical combination
HOENER MARIUS0 citations39
US8193408B2Jun 5, 2012
Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode gene
HOENER MARIUS0 citations37